D. E. Shaw & Co., Inc. - XENON PHARMACEUTICALS INC ownership

XENON PHARMACEUTICALS INC's ticker is XENE and the CUSIP is 98420N105. A total of 135 filers reported holding XENON PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 10.04 and the average weighting 0.4%.

Quarter-by-quarter ownership
D. E. Shaw & Co., Inc. ownership history of XENON PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$1,385,086
-63.6%
40,547
-58.9%
0.00%
-75.0%
Q2 2023$3,801,683
-48.6%
98,745
-52.2%
0.00%
-50.0%
Q1 2023$7,396,791
-48.0%
206,672
-42.7%
0.01%
-50.0%
Q4 2022$14,211,400
-3.9%
360,421
-12.0%
0.02%
-11.1%
Q3 2022$14,785,000
+48.8%
409,563
+25.4%
0.02%
+50.0%
Q2 2022$9,933,000
-1.7%
326,542
-1.2%
0.01%
+33.3%
Q1 2022$10,104,000
-31.9%
330,527
-30.4%
0.01%
-25.0%
Q4 2021$14,843,000
+552.4%
475,140
+219.1%
0.01%
+500.0%
Q3 2021$2,275,000
-25.5%
148,879
-9.3%
0.00%
-33.3%
Q2 2021$3,055,000
-2.5%
164,071
-6.2%
0.00%0.0%
Q1 2021$3,133,000
+10.9%
174,995
-4.8%
0.00%0.0%
Q4 2020$2,826,000
+32.7%
183,740
-4.5%
0.00%
+50.0%
Q3 2020$2,129,000
-19.0%
192,313
-8.3%
0.00%
-33.3%
Q2 2020$2,629,000
+62.7%
209,618
+47.1%
0.00%0.0%
Q1 2020$1,616,000
+162.8%
142,508
+204.0%
0.00%
+200.0%
Q4 2019$615,000
+121.2%
46,877
+51.7%
0.00%
Q3 2019$278,000
-8.3%
30,898
+0.4%
0.00%
Q2 2019$303,000
-46.4%
30,766
-44.7%
0.00%
-100.0%
Q1 2019$565,000
-31.8%
55,632
-57.6%
0.00%0.0%
Q4 2018$828,000131,2200.00%
Other shareholders
XENON PHARMACEUTICALS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Ghost Tree Capital, LLC 790,000$12,071,0003.53%
GREAT POINT PARTNERS LLC 700,000$10,696,0002.49%
COMMODORE CAPITAL LP 579,432$8,854,0002.33%
ACUTA CAPITAL PARTNERS, LLC 417,409$6,378,0002.25%
DAFNA Capital Management LLC 406,535$6,212,0001.65%
Tri Locum Partners LP 264,134$4,036,0001.60%
Parkman Healthcare Partners LLC 311,207$4,755,0001.20%
Ghost Tree Capital, LLC 250,000$3,820,0001.12%
Nan Fung Group Holdings Ltd 197,880$3,024,0000.97%
BVF INC/IL 1,571,778$24,017,0000.94%
View complete list of XENON PHARMACEUTICALS INC shareholders